Scarica l'app Stockscreener
358.24
1.16%
-4.20
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WST Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$362.44
Aprire:
$360.4
Volume 24 ore:
669.16K
Relative Volume:
0.81
Capitalizzazione di mercato:
$25.31B
Reddito:
$3.22B
Utile/perdita netta:
$542.70M
Rapporto P/E:
47.89
EPS:
7.4805
Flusso di cassa netto:
$458.00M
1 W Prestazione:
+1.28%
1M Prestazione:
+10.71%
6M Prestazione:
+37.90%
1 anno Prestazione:
+61.67%
Intervallo 1D:
$358.14
$366.14
Intervallo di 1 settimana:
$351.56
$366.30
Portata 52W:
$206.80
$367.66
West Pharmaceutical Services Inc Stock (WST) Company Profile
Nome
West Pharmaceutical Services Inc
Settore
Industria
Telefono
(610) 594-2900
Indirizzo
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
358.24 | 25.61B | 3.22B | 542.70M | 458.00M | 7.4805 |
ISRG
Intuitive Surgical Inc
|
345.42 | 142.49B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
158.17 | 44.07B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
70.26 | 34.44B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
39.79 | 34.76B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
198.99 | 29.41B | 5.54B | 1.52B | 1.74B | 10.37 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Iniziato | Morgan Stanley | Equal-Weight |
| 2025-09-15 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-06-24 | Iniziato | Barclays | Equal Weight |
| 2025-03-18 | Iniziato | Evercore ISI | Outperform |
| 2025-02-14 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2025-01-08 | Iniziato | Citigroup | Buy |
| 2024-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2024-12-12 | Aggiornamento | UBS | Neutral → Buy |
| 2024-02-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-06-16 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-04-11 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-11-30 | Iniziato | UBS | Neutral |
| 2022-10-28 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Iniziato | Stephens | Equal-Weight |
| 2020-07-21 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-04-24 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Downgrade | Jefferies | Buy → Hold |
| 2019-04-23 | Iniziato | William Blair | Outperform |
| 2018-04-25 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Iniziato | Goldman | Neutral |
| 2017-10-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Iniziato | Stephens | Equal-Weight |
| 2017-09-15 | Aggiornamento | Jefferies | Hold → Buy |
| 2016-10-28 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Iniziato | Wells Fargo | Outperform |
| 2010-05-14 | Reiterato | UBS | Neutral |
| 2010-02-23 | Iniziato | Jefferies & Co | Buy |
| 2008-12-19 | Iniziato | UBS | Neutral |
Mostra tutto
West Pharmaceutical Services Inc Borsa (WST) Ultime notizie
West Pharmaceutical stock trades steady as recent earnings highlight resilient demand and margin pre - ad-hoc-news.de
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch
ISRG Q2 Earnings Beat Estimates, Stock Falls on Slow Procedure Growth - TradingView
West Pharmaceutical stock trades near record levels as recent earnings and guidance underpin valuati - ad-hoc-news.de
Did West’s Expanded Daikyo Distribution Deal Reshape West Pharmaceutical Services' (WST) GLP‑1 Component Investment Narrative? - Yahoo Finance
West Pharmaceutical Services (WST) Expands Daikyo Ties As Valuation Questions Grow - Yahoo Finance
West Pharmaceutical Services (WST) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
West Pharmaceutical stock reflects steady medical packaging demand - Ad Hoc News
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now - Zacks Investment Research
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now - TradingView
West Pharmaceutical Services (WST) Enters Strategic Agreements w - GuruFocus
WST completes SmartDose sale to AbbVie to focus on core growth - MSN
West Pharmaceutical (NYSE: WST) inks 10-year Daikyo licensing, distribution deal - Stock Titan
Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry - Yahoo Finance
3 Reasons WST is Risky and 1 Stock to Buy Instead - Yahoo Finance
BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target - Moomoo
West Pharmaceutical Services, Inc. Stock 12‑Month Price Target Raised to $383.93, Implies 9% Upside - TradingView
West Synchrony Prefillable Syringe System Available at CPHI Southeast Asia - BioSpectrum Asia
West Pharmaceutical Services (WST) Sells SmartDose Rights, Is The Stock Fully Priced? - Sahm
West Pharmaceutical stock holds steady as drug-delivery leader builds on long-term growth story - Ad Hoc News
West Pharmaceutical Services (WST) Sells SmartDose Rights To AbbVie To Refocus Its Business - Yahoo Finance
Resmed Divests MatrixCare Business to Sharpen Focus on Connected Care - TradingView
West Pharmaceutical stock reflects steady demand for drug delivery components - Ad-hoc-news.de
The Bull Case For West Pharmaceutical Services (WST) Could Change Following Its Q1 2026 Earnings Beat And UpgradesLearn Why - Sahm
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharma Price Target Raised to $365.00/Share From $325.00 by Morgan Stanley - Moomoo
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now - TradingView
Morgan Stanley Adjusts Price Target on West Pharmaceutical Services to $365 From $325 - marketscreener.com
West Pharmaceutical Services, Inc. Stock 12‑Month Price Target Raised to $370.23, Implies 5% Upside - TradingView
WST Completes SmartDose Sale to AbbVie to Focus on Core Growth - Yahoo Finance
Morgan Stanley Maintains West Pharmaceutical Services(WST.US) With Hold Rating, Raises Target Price to $365 - Moomoo
West Pharmaceutical outlines long-term growth drivers as investors track U.S. healthcare demand - ad-hoc-news.de
West Launches Synchrony™ Prefillable Syringe System for Biologics and Vaccines in Southeast Asia - BioPharma APAC
WST stock up nearly 33% YTD: Will the uptrend continue in the rest of 2026? - MSN
The Daikyo D2F Series PlungerWest Pharmaceutical focuses on high-barrier safety for prefilled syr - Ad-hoc-news.de
West Pharmaceutical Services (WST) Is Up 4.24% in One Week: What You Should Know - Yahoo Finance
Here's Why You Should Retain AMN Stock in Your Portfolio for Now - TradingView
West to Host Second-Quarter 2026 Conference Call - BioSpace
West Pharmaceutical sets July 23 call for Q2 2026 results - Stock Titan
WST Maintains Rating by Evercore ISI Group -- Price Target Raises to $410 - GuruFocus
West Pharmaceutical Services Inc. stock underperforms Monday when compared to competitors - MarketWatch
West Pharmaceutical updates strategy as global demand for drug delivery grows - AD HOC NEWS
West Pharmaceutical Services (WST) Stock Looks Overvalued Despite Upcoming Q2 Earnings - Yahoo Finance
WST Stock Up Nearly 33% YTD: Will the Uptrend Continue in the Rest of 2026? - TradingView
Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? L - The National Law Review
West Pharmaceutical Services Stock 10-Day Winning Spree: Stock Climbs 13% - Trefis
West Pharmaceutical rises on upbeat results, guidance raise - MSN
Here's Why You Should Retain McKesson Stock in Your Portfolio for Now - TradingView
West completes sale of on-body drug delivery device to AbbVie - Drug Delivery Business
West Pharmaceutical Services Stock Rockets 13% With 9-Day Winning Streak - Trefis
What to Expect From West Pharmaceutical Services' Q2 2026 Earnings Report - Yahoo Finance
West Pharmaceutical Services Inc Azioni (WST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):